<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>High throughput screening data for a case study of CHO cell culture process development</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Qin</namePart>
      <namePart type="family">He</namePart>
      <displayForm>He, Qin</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jianlin</namePart>
      <namePart type="family">Xu</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-6441-0696</nameIdentifier>
      <displayForm>Xu, Jianlin</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Erik</namePart>
      <namePart type="family">Vandermark</namePart>
      <displayForm>Vandermark, Erik</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jun</namePart>
      <namePart type="family">Tian</namePart>
      <displayForm>Tian, Jun</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Yueming</namePart>
      <namePart type="family">Qian</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0001-7340-6421</nameIdentifier>
      <displayForm>Qian, Yueming</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Cynthia</namePart>
      <namePart type="family">Chelius</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0001-5906-8411</nameIdentifier>
      <displayForm>Chelius, Cynthia</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jongchan</namePart>
      <namePart type="family">Lee</namePart>
      <displayForm>Lee, Jongchan</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Michael C.</namePart>
      <namePart type="family">Borys</namePart>
      <displayForm>Borys, Michael C.</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Zheng Jian</namePart>
      <namePart type="family">Li</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-1941-4145</nameIdentifier>
      <displayForm>Li, Zheng Jian</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Girish</namePart>
      <namePart type="family">Pendse</namePart>
      <displayForm>Pendse, Girish</displayForm>
      <affiliation>Biologics Development, Global Product Development and Supply, Bristol-Myers Squibb, Summit, NJ 07901, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2021-12</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>In this article, we present four sets of data from high-throughput screening (HTS) studies of different chemically defined media using an industrially relevant Chinese hamster ovary (CHO) cell line. While complex hydrolysate media was used in the early phase process development and manufacturing of a monoclonal antibody (mAb), here we seek to determine an appropriate chemically defined media for late phase process development. Over 150 combinations of chemically defined basal media, feed media, and basal and feed media supplements, such as polyphenolic flavonoid antioxidants (including rosmarinic acid (RA)), were evaluated in four HTS studies to replace the complex hydrolysate media. Specifically, these four screening studies incorporated custom design of experiment (DOE), one-factor-at-a-time (OFAT), and definitive screening design methodologies for titer improvement. Titer was improved two fold compared to the early phase process using the addition of RA to chemically defined media. This dataset exemplifies how HTS can be used as an effective approach to systematically and statistically determine media composition and supplementation to increase mAb titer. These data were presented in connection with a published paper [1]. </abstract>
   <subject>
      <topic>CHO cell culture</topic>
   </subject>
   <subject>
      <topic>High-throughput screening</topic>
   </subject>
   <subject>
      <topic>Rosmarinic acid</topic>
   </subject>
   <subject>
      <topic>Monoclonal antibody titer</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Data in Brief</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier Inc.</publisher>
      </originInfo>
      <identifier type="issn">2352-3409</identifier>
      <part>
         <detail type="volume">
            <number>39</number>
            <caption>v.</caption>
         </detail>
         <text type="display-date">December 2021</text>
         <text type="year">2021</text>
         <text type="month">December</text>
         <extent unit="pages">
            <start>107491</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.dib.2021.107491</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.dib.2021.107491</url>
   </location>
   <identifier type="pii">S2352-3409(21)00772-1</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2021-10-14"/>
         <licence_ref>http://creativecommons.org/licenses/by/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/164128545923847224-00001/2352-3409/S2352340921X00066/S2352340921007721/S2352340921007721.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
